The tyrosine phosphatase STEP is a developmental suppressor of synaptogenesis

J Joel P. Pires (Center for Neuroscience and Cell Biology, University of Coimbra) D Diogo Tomé (Center for Neuroscience and Cell Biology, University of Coimbra) M Miranda Mele (Center for Neuroscience and Cell Biology, University of Coimbra) A Ana Caulino-Rocha (Center for Innovative Biomedicine and Biotechnology, University of Coimbra) E Elisa Corti (Center for Neuroscience and Cell Biology, University of Coimbra) I Ira Milosevic (Multidisciplinary Institute of Aging, Center for Innovative Biomedicine and Biotechnology, University of Coimbra) G Graça F. Baltazar (Health Sciences Research Centre, University of Beira Interior) R Ramiro D. Almeida (Center for Neuroscience and Cell Biology, University of Coimbra)

Abstract

Striatal-Enriched Protein Tyrosine Phosphatase (STEP) constrains synaptic potentiation by dephosphorylating postsynaptic substrates, but its presynaptic role has remained unclear. Here, we identify a previously unrecognized function of STEP in regulating axonal differentiation and synapse assembly. Genetic and pharmacological manipulation of STEP in vivo and in vitro show that STEP limits presynaptic maturation by restricting synaptic vesicle protein clustering along developing hippocampal axons. Using a reconstituted circuit-on-a-chip we show that loss of presynaptic STEP is sufficient to significantly increase the number of axodendritic synapses. Functional imaging further revealed that the increased synaptic puncta observed in STEP KO neurons actively undergo depolarization-evoked vesicle exocytosis, representing bona fide functional synapses. Multielectrode array recordings reveal that STEP deletion increases neuronal excitability, and network synchrony, hallmarks of enhanced presynaptic efficacy. Mechanistically, these effects reflect sustained phosphorylation of STEP promoting presynaptic assembly and release competence. Importantly, inhibiting STEP also rescues presynaptic differentiation defects in Fmr1 KO neurons, implicating aberrant STEP signaling in Fragile X–associated synaptic pathology. Thus, STEP serves as a phosphatase gatekeeper that restrains presynaptic differentiation and neurotransmission, and its inhibition may offer a therapeutic strategy to correct synaptic deficits in Fragile X Syndrome.

Article Details

Volume / Issue Vol. 123, Issue 24
Published June 16, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (8)

J

Joel P. Pires

Center for Neuroscience and Cell Biology, University of Coimbra

D

Diogo Tomé

Center for Neuroscience and Cell Biology, University of Coimbra

M

Miranda Mele

Center for Neuroscience and Cell Biology, University of Coimbra

A

Ana Caulino-Rocha

Center for Innovative Biomedicine and Biotechnology, University of Coimbra

E

Elisa Corti

Center for Neuroscience and Cell Biology, University of Coimbra

I

Ira Milosevic

Multidisciplinary Institute of Aging, Center for Innovative Biomedicine and Biotechnology, University of Coimbra

G

Graça F. Baltazar

Health Sciences Research Centre, University of Beira Interior

R

Ramiro D. Almeida

Center for Neuroscience and Cell Biology, University of Coimbra